India AC Firms Face LPG Crisis: Costs Jump, Prices to Rise for Consumers

INDUSTRIAL-GOODSSERVICES
Whalesbook Logo
AuthorRiya Kapoor|Published at:
India AC Firms Face LPG Crisis: Costs Jump, Prices to Rise for Consumers
Overview

Indian air conditioner manufacturers are grappling with a critical Liquefied Petroleum Gas (LPG) shortage, directly disrupting production processes. The government's prioritization of household supply has left commercial users struggling, forcing companies to adopt costly alternatives and pass on price hikes to consumers just as summer demand looms.

LPG Shortage Disrupts AC Production

The core issue lies in heat exchanger brazing, a crucial step for AC assembly where LPG offers the most efficient method. However, LPG supplies are restricted by government policy, which prioritizes household use amidst broader supply chain issues. This forces manufacturers to seek alternatives.

Rising Costs and Supply Chain Risks

Major manufacturers are switching to oxy-acetylene for brazing to keep production lines running. But this alternative fuel is also subject to supply risks, as it depends on crude oil or limestone. Nuvama reports highlight that 94% of India's limestone imports come from the Middle East, adding another layer of supply chain risk.

Price Hikes and Margin Pressure

These fuel supply challenges add to existing pressures. Unseasonal rains in northern India have already dampened consumer demand after a slow summer last year. To cope with rising input costs, companies are implementing retail price increases of 5% to 10%.

LG Electronics India is a prime example of this trend, announcing a 10% price hike for Room Air Conditioners (RACs) and 5% across other product categories. This follows an earlier 9-10% increase on RACs since early 2026. The combined effect of cost inflation and new, stricter star rating regulations means total price increases are now between 8% and 14%.

While brands expect modest revenue growth in the fourth quarter of fiscal year 2026, Electronic Manufacturing Services (EMS) providers face substantial challenges to both their revenue and profit margins. Using oxy-acetylene, while ensuring operational continuity, comes at a higher cost, significantly impacting profitability for those unable to absorb these expenses.

Disclaimer:This content is for informational purposes only and does not constitute financial or investment advice. Readers should consult a SEBI-registered advisor before making decisions. Investments are subject to market risks, and past performance does not guarantee future results. The publisher and authors are not liable for any losses. Accuracy and completeness are not guaranteed, and views expressed may not reflect the publication’s editorial stance.